Masimo Corp
NASDAQ:MASI
Masimo Corp
Interest Income Expense
Masimo Corp
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Masimo Corp
NASDAQ:MASI
|
Interest Income Expense
-$48.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$549m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Masimo Corp's Interest Income Expense?
Interest Income Expense
-48.4m
USD
Based on the financial report for Dec 30, 2023, Masimo Corp's Interest Income Expense amounts to -48.4m USD.
What is Masimo Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-192%
Over the last year, the Interest Income Expense growth was -192%.